JNJ: Johnson & Johnson Stocks News on April 1, 2025

JNJ

MT Newswires

7 hours ago

Sector Update: Health Care

Bankruptcy judge denies J&J settlement plan related to baby powder containing talc

JNJ

Associated Press Finance

8 hours ago

Bankruptcy judge denies J&J settlement plan related to baby powder containing talc

Johnson & Johnson Stock Falls After Latest Talc Resolution Rejected by Judge

JNJ

Barrons.com

8 hours ago

Johnson & Johnson Stock Falls After Latest Talc Resolution Rejected by Judge

Nvidia, Other Techs Hurt Dow Jones, But These Names Outperformed In Q1

JNJ

Investor's Business Daily

8 hours ago

Nvidia, Other Techs Hurt Dow Jones, But These Names Outperformed In Q1

JNJ

Investing.com

8 hours ago

J&J stock drops after failed attempt to end talc claims

JNJ

Argus Research

9 hours ago

Technical Assessment: Neutral in the Intermediate-Term

J&J shares fall after judge rejects $10 billion talc settlement

JNJ

Reuters

9 hours ago

J&J shares fall after judge rejects $10 billion talc settlement

JNJ

MT Newswires

12 hours ago

Johnson & Johnson Faces Setback as Bankruptcy Court Denies Talc Settlement Plan

Johnson & Johnson (JNJ): Among the Best Dividend Aristocrat Stocks with Over 3% Yield

JNJ

Insider Monkey

a day ago

Johnson & Johnson (JNJ): Among the Best Dividend Aristocrat Stocks with Over 3% Yield

1 Healthcare Stock to Target This Week and 2 to Turn Down

JNJ

StockStory

a day ago

1 Healthcare Stock to Target This Week and 2 to Turn Down

Jim Cramer on Johnson & Johnson (NYSE:JNJ): Their Spinoff Was Ill-Advised

JNJ

Insider Monkey

3 days ago

Jim Cramer on Johnson & Johnson (NYSE:JNJ): Their Spinoff Was Ill-Advised

3 Relatively Safe Stocks to Buy Right Now

JNJ

Motley Fool

3 days ago

3 Relatively Safe Stocks to Buy Right Now

JNJ

MT Newswires

4 days ago

Sector Update: Health Care Stocks Softer Late Afternoon

JNJ

MT Newswires

4 days ago

Sector Update: Health Care

JNJ

MT Newswires

4 days ago

Johnson & Johnson's Janssen Unit Ordered to Pay US About $1.64 Billion in HIV Drug Marketing Case

Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case

JNJ

Reuters

4 days ago

Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case

J&J launches energy generator compatible with Ottava robot

JNJ

MedTech Dive

4 days ago

J&J launches energy generator compatible with Ottava robot

2 Reasons to Like JNJ and 1 to Stay Skeptical

JNJ

StockStory

4 days ago

2 Reasons to Like JNJ and 1 to Stay Skeptical

Johnson & Johnson (NYSE:JNJ) Presents Promising Nipocalimab Data At AAN Annual Meeting

JNJ

Simply Wall St.

5 days ago

Johnson & Johnson (NYSE:JNJ) Presents Promising Nipocalimab Data At AAN Annual Meeting

J&J says Rybrevant/Lazcluze outperforms osimertinib OS in Phase 3 study

JNJ

TipRanks

5 days ago

J&J says Rybrevant/Lazcluze outperforms osimertinib OS in Phase 3 study

U.S. to end funding for child vaccines in developing countries, NY Times reports

JNJ

TipRanks

5 days ago

U.S. to end funding for child vaccines in developing countries, NY Times reports

How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain

JNJ

Investor's Business Daily

5 days ago

How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain

Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know

JNJ

Zacks

5 days ago

Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know

J&J’s NSCLC combo projected to extend survival by one year over Tagrisso

JNJ

Clinical Trials Arena

5 days ago

J&J’s NSCLC combo projected to extend survival by one year over Tagrisso

2 Recession-Proof Dividend Stocks to Buy and Hold

JNJ

Motley Fool

5 days ago

2 Recession-Proof Dividend Stocks to Buy and Hold

Johnson & Johnson MedTech introduces electrosurgical generator

JNJ

Medical Device Network

6 days ago

Johnson & Johnson MedTech introduces electrosurgical generator

New nipocalimab data and real-world research at AAN 2025 highlight positive Phase 3 results and commitment to people living with generalized myasthenia gravis (gMG)

JNJ

PR Newswire

6 days ago

New nipocalimab data and real-world research at AAN 2025 highlight positive Phase 3 results and commitment to people living with generalized myasthenia gravis (gMG)

Johnson & Johnson (JNJ) Stock Dips While Market Gains: Key Facts

JNJ

Zacks

8 days ago

Johnson & Johnson (JNJ) Stock Dips While Market Gains: Key Facts

ACIU Stock Crashes 18.3% in a Month: Buy, Sell or Hold?

JNJ

Zacks

8 days ago

ACIU Stock Crashes 18.3% in a Month: Buy, Sell or Hold?

JNJ

MT Newswires

8 days ago

Update: Market Chatter: Kenvue Urged by TOMS Capital to Consider Sale, Spinoff of Assets

Is Johnson & Johnson (JNJ) The Best Healthcare Dividend Stock to Invest in?

JNJ

Insider Monkey

8 days ago

Is Johnson & Johnson (JNJ) The Best Healthcare Dividend Stock to Invest in?

JNJ

Zacks

8 days ago

Take the Zacks Approach to Beat the Markets: CMS Energy, Chevron, AutoZone in Focus

JNJ

MT Newswires

8 days ago

Market Chatter: Kenvue Urged by TOMS Capital to Consider Sale, Spinoff of Assets

Here's How to Play JNJ Stock as it Announces $55B US Investment Plan

JNJ

Zacks

8 days ago

Here's How to Play JNJ Stock as it Announces $55B US Investment Plan

Was Jim Cramer Right About Johnson & Johnson (JNJ)?

JNJ

Insider Monkey

10 days ago

Was Jim Cramer Right About Johnson & Johnson (JNJ)?

Johnson & Johnson is the latest pharma giant to court Trump with new investment plans

JNJ

Quartz

11 days ago

Johnson & Johnson is the latest pharma giant to court Trump with new investment plans

J&J boosts US operations with $55bn investment

JNJ

Pharmaceutical Technology

11 days ago

J&J boosts US operations with $55bn investment

JNJ

MT Newswires

11 days ago

Sector Update: Health Care Stocks Fall in Afternoon Trading

JNJ

MT Newswires

11 days ago

The Art of Valuation: Discovering Johnson & Johnson's Intrinsic Value

JNJ

Investing.com

11 days ago

J&J is latest company trying to get on Trump's good side with big U.S. investment

Johnson & Johnson Boosts Planned US Investment to More Than $55 Billion

JNJ

MT Newswires

11 days ago

Johnson & Johnson Boosts Planned US Investment to More Than $55 Billion

Johnson & Johnson to Invest Over $55 Billion in U.S. in Next Four Years

JNJ

The Wall Street Journal

11 days ago

Johnson & Johnson to Invest Over $55 Billion in U.S. in Next Four Years

J&J's Tremfya Gets FDA Nod for 2nd IBD Condition Crohn's Disease

JNJ

Zacks

11 days ago

J&J's Tremfya Gets FDA Nod for 2nd IBD Condition Crohn's Disease

FDA Approves Johnson & Johnson's Tremfya For Crohn's Disease

JNJ

Benzinga

11 days ago

FDA Approves Johnson & Johnson's Tremfya For Crohn's Disease

Johnson & Johnson plans $55 billion in US investments over the next four years

JNJ

Associated Press Finance

11 days ago

Johnson & Johnson plans $55 billion in US investments over the next four years

JNJ

MT Newswires

11 days ago

Johnson & Johnson to Invest Over $55 Billion in US Over Next Four Years

J&J boosts investments in US to more than $55 billion amid looming tariff threats

JNJ

Reuters

11 days ago

J&J boosts investments in US to more than $55 billion amid looming tariff threats

Johnson & Johnson Increases U.S. Investment to More than $55 Billion Over the Next Four Years

JNJ

Business Wire

11 days ago

Johnson & Johnson Increases U.S. Investment to More than $55 Billion Over the Next Four Years

JNJ

MT Newswires

11 days ago

Johnson & Johnson's Tremfya Receives US FDA Approval for Crohn's Disease

FDA approves Johnson & Johnson’s Tremfya to treat Crohn’s disease

JNJ

Pharmaceutical Technology

11 days ago

FDA approves Johnson & Johnson’s Tremfya to treat Crohn’s disease

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) significantly outperforms standard of care in first-line EGFR-mutated lung cancer with compelling new data at ELCC 2025

JNJ

PR Newswire

12 days ago

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) significantly outperforms standard of care in first-line EGFR-mutated lung cancer with compelling new data at ELCC 2025

JNJ's Nipocalimab Gets FDA's Fast Track Tag for Sjogren's Disease

JNJ

Zacks

13 days ago

JNJ's Nipocalimab Gets FDA's Fast Track Tag for Sjogren's Disease

JNJ

Zacks

13 days ago

The Zacks Analyst Blog Highlights Visa, Johnson & Johnson, Thermo Fisher and AMREP

Top Stock Reports for Visa, Johnson & Johnson & Thermo Fisher Scientific

JNJ

Zacks

14 days ago

Top Stock Reports for Visa, Johnson & Johnson & Thermo Fisher Scientific

Johnson & Johnson (NYSE:JNJ) Gains FDA Fast Track For Nipocalimab In Treating Sjogren's Disease

JNJ

Simply Wall St.

14 days ago

Johnson & Johnson (NYSE:JNJ) Gains FDA Fast Track For Nipocalimab In Treating Sjogren's Disease

JNJ

MT Newswires

14 days ago

Johnson & Johnson Says US FDA Grants Fast Track Designation for Sjogren's Disease Treatment

Nipocalimab, the first and only investigational treatment to be granted U.S. FDA Breakthrough Therapy designation for the treatment of adults with moderate-to-severe Sjögren's disease, has now received Fast Track designation

JNJ

PR Newswire

14 days ago

Nipocalimab, the first and only investigational treatment to be granted U.S. FDA Breakthrough Therapy designation for the treatment of adults with moderate-to-severe Sjögren's disease, has now received Fast Track designation

Got $300? Buy These 3 Top Dividend Stocks and Never Look Back.

JNJ

Motley Fool

14 days ago

Got $300? Buy These 3 Top Dividend Stocks and Never Look Back.

Jim Cramer Says Johnson & Johnson (JNJ) Stock Could Fall to $160 Level

JNJ

Insider Monkey

15 days ago

Jim Cramer Says Johnson & Johnson (JNJ) Stock Could Fall to $160 Level

Johnson & Johnson (JNJ) Rises But Trails Market: What Investors Should Know

JNJ

Zacks

15 days ago

Johnson & Johnson (JNJ) Rises But Trails Market: What Investors Should Know

JNJ

MT Newswires

15 days ago

Nanobiotix Amends Licensing Deal With Johnson & Johnson

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

JNJ

Zacks

15 days ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

The S&P 500 Is in Correction Territory: 4 Surefire Stocks to Buy Right Now

JNJ

Motley Fool

15 days ago

The S&P 500 Is in Correction Territory: 4 Surefire Stocks to Buy Right Now

Johnson & Johnson (JNJ) Could Be a Great Choice

JNJ

Zacks

18 days ago

Johnson & Johnson (JNJ) Could Be a Great Choice

Hostage to Legal Decisions – Here’s Why Jim Cramer Gave Up on Johnson & Johnson (JNJ)

JNJ

Insider Monkey

18 days ago

Hostage to Legal Decisions – Here’s Why Jim Cramer Gave Up on Johnson & Johnson (JNJ)

Zimmer Biomet Focuses on Innovation Amid Growing Competition

JNJ

Zacks

18 days ago

Zimmer Biomet Focuses on Innovation Amid Growing Competition

Big Pharma Walked Away From Mental Health. Why Some Are Coming Back.

JNJ

The Wall Street Journal

18 days ago

Big Pharma Walked Away From Mental Health. Why Some Are Coming Back.

Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks

JNJ

StockStory

18 days ago

Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks

Johnson & Johnson (JNJ): “Breakout or Breakdown?” – Jim Cramer Says JNJ Must Fall for Market to Bottom

JNJ

Insider Monkey

19 days ago

Johnson & Johnson (JNJ): “Breakout or Breakdown?” – Jim Cramer Says JNJ Must Fall for Market to Bottom

Johnson & Johnson (NYSE:JNJ) Faces Shareholder Activism Over Human Rights and Executive Pay Proposals

JNJ

Simply Wall St.

19 days ago

Johnson & Johnson (NYSE:JNJ) Faces Shareholder Activism Over Human Rights and Executive Pay Proposals

FDA grants 510(k) clearance for J&J MedTech’s Monarch Quest

JNJ

Medical Device Network

19 days ago

FDA grants 510(k) clearance for J&J MedTech’s Monarch Quest

J&J’s Monarch robot wins FDA nod for AI software update

JNJ

MedTech Dive

19 days ago

J&J’s Monarch robot wins FDA nod for AI software update

Why Johnson & Johnson (JNJ) is the Best Pharma Stock to Buy According to Hedge Funds

JNJ

Insider Monkey

20 days ago

Why Johnson & Johnson (JNJ) is the Best Pharma Stock to Buy According to Hedge Funds

JNJ

MT Newswires

20 days ago

Johnson & Johnson's MedTech Gets US FDA Approval for Monarch Quest

Johnson & Johnson (JNJ): Among Dobermans of the Dow to Buy

JNJ

Insider Monkey

20 days ago

Johnson & Johnson (JNJ): Among Dobermans of the Dow to Buy

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know

JNJ

Zacks

20 days ago

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know

A new obesity biotech launches; Gilead plans to quickly advance once-yearly PrEP for HIV

JNJ

BioPharma Dive

20 days ago

A new obesity biotech launches; Gilead plans to quickly advance once-yearly PrEP for HIV

Johnson & Johnson (NYSE:JNJ) Reports Positive Phase 2b Trial Results For Ulcerative Colitis Treatment

JNJ

Simply Wall St.

21 days ago

Johnson & Johnson (NYSE:JNJ) Reports Positive Phase 2b Trial Results For Ulcerative Colitis Treatment

PTGX Up as J&J-Partnered Drug Meets Goal in Ulcerative Colitis Study

JNJ

Zacks

21 days ago

PTGX Up as J&J-Partnered Drug Meets Goal in Ulcerative Colitis Study

Is Johnson & Johnson (JNJ) the Best Low Risk Stock to Buy In 2025?

JNJ

Insider Monkey

21 days ago

Is Johnson & Johnson (JNJ) the Best Low Risk Stock to Buy In 2025?

Genmab says J&J not exercising option on HexaBody-CD38

JNJ

TipRanks

21 days ago

Genmab says J&J not exercising option on HexaBody-CD38

Protagonist Therapeutics Soars as Icotrokinra Drives Breakthrough Success

JNJ

GuruFocus.com

21 days ago

Protagonist Therapeutics Soars as Icotrokinra Drives Breakthrough Success

J&J and Protagonist’s icotrokinra scores in Phase IIb UC study

JNJ

Clinical Trials Arena

21 days ago

J&J and Protagonist’s icotrokinra scores in Phase IIb UC study

JNJ

Investing.com

21 days ago

Genmab sinks as J&J opts not to develop Darzalex successor; stock upgraded

Are High-Yield Dividend Stocks Best for Income-Focused Investors?

JNJ

Zacks

22 days ago

Are High-Yield Dividend Stocks Best for Income-Focused Investors?

Protagonist Therapeutics Unveils 'Paradigm-Shifting' Drug And Breaks Out

JNJ

Investor's Business Daily

22 days ago

Protagonist Therapeutics Unveils 'Paradigm-Shifting' Drug And Breaks Out

How Exxon Mobil, Johnson & Johnson, And Cogent Communications Can Put Cash In Your Pocket

JNJ

Benzinga

22 days ago

How Exxon Mobil, Johnson & Johnson, And Cogent Communications Can Put Cash In Your Pocket

Johnson & Johnson's Ulcerative Colitis Drug Hits Key Trial Goals, Stock Rises

JNJ

GuruFocus.com

22 days ago

Johnson & Johnson's Ulcerative Colitis Drug Hits Key Trial Goals, Stock Rises

JNJ

Zacks

22 days ago

Zacks Investment Ideas feature highlights: Coca-Cola, Philip Morris and Johnson & Johnson

JNJ

MT Newswires

22 days ago

Protagonist, Johnson & Johnson Say Phase 2b Icotrokinra Study Meets Primary Endpoint in Ulcerative Colitis

JNJ

MT Newswires

22 days ago

Johnson & Johnson Gets Health Canada Approval for Lung Cancer Drug Combination

JNJ

MT Newswires

22 days ago

Johnson & Johnson's Investigational Colitis Treatment Meets Primary Endpoint in Phase 2b Trial

Health Canada authorizes LAZCLUZE® (lazertinib) in combination with RYBREVANT® (amivantamab) as a first-line chemotherapy-free treatment for patients with EGFR-mutated advanced lung cancer

JNJ

CNW Group

22 days ago

Health Canada authorizes LAZCLUZE® (lazertinib) in combination with RYBREVANT® (amivantamab) as a first-line chemotherapy-free treatment for patients with EGFR-mutated advanced lung cancer

Icotrokinra meets primary endpoint of clinical response in ulcerative colitis study and shows potential to transform the treatment paradigm for patients

JNJ

PR Newswire

22 days ago

Icotrokinra meets primary endpoint of clinical response in ulcerative colitis study and shows potential to transform the treatment paradigm for patients

JNJ

Argus Research

22 days ago

Technical Assessment: Neutral in the Intermediate-Term

Is Johnson & Johnson (JNJ) the Best Performing Dividend Stock to Buy Now?

JNJ

Insider Monkey

23 days ago

Is Johnson & Johnson (JNJ) the Best Performing Dividend Stock to Buy Now?

CDC plans study into potential vaccines, autism connections, Reuters reports

JNJ

TipRanks

24 days ago

CDC plans study into potential vaccines, autism connections, Reuters reports

Icotrokinra results show potential to set a new standard of treatment in plaque psoriasis

JNJ

PR Newswire

24 days ago

Icotrokinra results show potential to set a new standard of treatment in plaque psoriasis

Buy Gilead Sciences (GILD) Stock at 52-Week Highs?

JNJ

Zacks

24 days ago

Latest Johnson & Johnson (JNJ) News on April 1, 2025

Share on Social Networks: